Skip to content
healthcare.dev

BUPRENORPHINE AND NALOXONE

NDC 67877-606, BUPRENORPHINE AND NALOXONE, tablet, from Ascend Laboratories, LLC.

Product NDC
67877-606
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214930
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-606 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE8 mg/1
  • NALOXONE HYDROCHLORIDE2 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
67877-606-306787706063030 TABLET in 1 BOTTLE (67877-606-30)
67877-606-84678770606843 BLISTER PACK in 1 CARTON (67877-606-84) / 10 TABLET in 1 BLISTER PACK
67877-606-906787706069090 TABLET in 1 BOTTLE (67877-606-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2e807ed0-6df3-47b5-b7ee-b421c5bf0aa7

Use it

Look up 67877-606 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-606 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-606. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.